Where to buy Vandetanib

Vandetanib (Vandetanib) is used to treat medullary thyroid cancer that cannot be treated with surgery or has spread to different parts of the body. The drug is only available under a program called vandetanib REMS (Risk Assessment and Mitigation Strategies). Patients must weigh the risks and benefits of taking this drug before using it. Treatment with vandetanib should be initiated and supervised by a doctor experienced in treating medullary thyroid cancer, using anticancer drugs, and evaluating an electrocardiogram (ECG, a test that measures the electrical activity of the heart).

Vandetanib is available by prescription only and is available in tablets (100 mg and 300 mg). The recommended dose for adults is 300 mg once daily, taken at about the same time each day. Patients who cannot swallow the tablets can mix the tablets in plain (non-bubbly) water. If a patient develops EKG abnormalities or serious side effects, doctors may temporarily stop vandetanib treatment and reduce the dose. Treatment continues as long as the patient benefits from it. Vandetanib may not work well in patients who do not have mutations (changes) in the "rearranged upon transfection" (RET) gene, and doctors are advised to check for RET mutations when starting treatment with vandetanib.

The original drug of vandetanib has not yet been launched in China, so it is not included in the medical insurance. Domestic patients cannot yet purchase this drug. The original drug specifications of vandetanib listed overseasThe price of each box of 300mg*30 tablets may be more than 30,000 yuan (the price may fluctuate due to the exchange rate). There is currently no generic drug of vandetanib produced and launched. For more drug information and specific prices, please consult the medical consultant of Yaode.